Chen J - Search Results

1

Safety and efficacy of co-administration of CD19 and CD22 CAR-T cells in children with B-ALL relapse after CD19 CAR-T therapy.

Li W, Ding L, Shi W, Wan X, Yang X, Yang J, Wang T, Song L, Wang X, Ma Y, Luo C, Tang J, Gu L, Chen J, Lu J, Tang Y, Li B. Li W, et al. Among authors: chen j. J Transl Med. 2023 Mar 22;21(1):213. doi: 10.1186/s12967-023-04019-4. J Transl Med. 2023. PMID: 36949487 Free PMC article.

2

[Primary study on establishment of namalwa 12/MTX resistant cell strain and its mechanism].

Chen J, Gu LJ, Ying DM, Shen M, Wu HJ. Chen J, et al. Ai Zheng. 2002 Dec;21(12):1335-40. Ai Zheng. 2002. PMID: 12520743 Chinese.

3

[Detection of minimal residual disease in childhood B-ALL by flow cytometry].

Xu C, Zhao HJ, Wu ZH, Xue HL, Tang JY, Chen J, Pan C, Chen J, Li L, Gu LJ, Shen LS. Xu C, et al. Among authors: chen j. Zhonghua Xue Ye Xue Za Zhi. 2003 Jun;24(6):295-9. Zhonghua Xue Ye Xue Za Zhi. 2003. PMID: 12859864 Chinese.

4

[Characterization of CD10 expression and its significance in minimal residual disease detection in childhood B-acute lymphoblastic leukemia].

Zhao HJ, Xu C, Chen J, Wu ZH, Xue HL, Tang JY, Pan C, Chen J, Li L, Gu LJ, Shen LS. Zhao HJ, et al. Among authors: chen j. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2003 Aug;11(4):350-4. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2003. PMID: 12962560 Chinese.

5

[Analysis on GST-Pi genetic polymorphism in children with acute leukemia].

Yuan XJ, Gu LJ, Xue HL, Tang JY, Zhao JC, Chen J, Wang YP, Chen J, Pan C, Song DL. Yuan XJ, et al. Among authors: chen j. Zhonghua Yi Xue Za Zhi. 2003 Nov 10;83(21):1863-6. Zhonghua Yi Xue Za Zhi. 2003. PMID: 14642067 Chinese.

6

[Application of CD34+ autologous peripheral progenitor cell transplant in the treatment of children with refractory SLE].

Chen J, Gu LJ, Zhao HJ, Xue HL, Zheng Y, Xie XJ, Chen J, Li L, Xu C, Wang YP. Chen J, et al. Zhonghua Er Ke Za Zhi. 2003 Jun;41(6):426-9. Zhonghua Er Ke Za Zhi. 2003. PMID: 14748997 Chinese.

7

[Analysis of therapeutic effectiveness in 158 childhood acute lymphoblastic leukemia patients treated with ALL-XH-99 protocol].

Gu LJ, Li J, Xue HL, Tang JY, Chen J, Zhao HJ, Chen J, Ye H, Wang YP, Pan C. Gu LJ, et al. Among authors: chen j. Zhonghua Xue Ye Xue Za Zhi. 2004 Jan;25(1):1-4. Zhonghua Xue Ye Xue Za Zhi. 2004. PMID: 14990066 Clinical Trial. Chinese.

8

[Response rate of AML-XH-99 protocol in the treatment of 82 childhood acute myeloid leukemia].

Li J, Gu LJ, Xue HL, Tang JY, Chen J, Zhao HJ, Chen J, Pan C, Wang YP, Ye H. Li J, et al. Among authors: chen j. Zhonghua Xue Ye Xue Za Zhi. 2004 Jun;25(6):351-4. Zhonghua Xue Ye Xue Za Zhi. 2004. PMID: 15308014 Chinese.

9

[Treatment of advanced malignant solid tumors in children with autologous hematopoietic stem cell transplantation].

Chen J, Gu LJ, Tang JY, Zhao HJ, Pan C, Xue HL, Chen J, Wang YP. Chen J, et al. Zhonghua Er Ke Za Zhi. 2004 Dec;42(12):924-7. Zhonghua Er Ke Za Zhi. 2004. PMID: 15733364 Chinese.

10

[Prognostic value of both detection of lymphoblasts in the period of early treatment and minimal residual disease in childhood acute lymphoblastic leukemia].

Tie LJ, Gu LJ, Song DL, Jiang LM, Xue HL, Tang JY, Dong L, Pan C, Chen J, Ye H, Wang YP, Chen J. Tie LJ, et al. Among authors: chen j. Zhonghua Xue Ye Xue Za Zhi. 2005 Jan;26(1):6-9. Zhonghua Xue Ye Xue Za Zhi. 2005. PMID: 15946500 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138,449 results

Search Page

Filters